Form D · Biotechnology
TRANSGENRX INC
Baton Rouge, LA · CIK 0001274562
Offering snapshot reported Sep 9, 2011 · SEC filing
- Reported sold
- $6.51M Offering amount: $15M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 14, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 42
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2011 | Amendment | $6,505,600 | No comparison | 42 | SEC filing |
| Sep 28, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 4, 2010 | Initial | $420,000 | No comparison | 4 | SEC filing |
| Oct 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $725K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-148237
Does not include warrant compensation.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MidAmerica Financial Services, Inc. | 47351 |
Source: Form D, filed Sep 9, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas H. Altschuler | Director |
| Richard C. Cooper | Director, Executive |
| Victor Filatov | Executive |
| William C. Fioretti | Director, Executive |
| John B. Gallagher | Director, Executive |
| Robert Kenney | Director |
| Philipe Tremml | Executive |
| Philippe Tremml | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
340 East Parker Blvd
Baton Rouge, LA, 70803
Baton Rouge, LA, 70803